Navigation Links
Cell Therapeutics Announces Sale of Convertible Preferred Stock
Date:9/12/2013

SEATTLE, Sept. 13, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced that it has agreed to sell 15,000 shares of its Series 18 Preferred Stock directly to Quogue Capital LLC and an affiliate of Perceptive Advisors LLC in a registered direct offering conducted without an underwriter or placement agent for gross proceeds of approximately $15 million (the "Offering").  The net proceeds from the Offering, after deducting estimated offering expenses, will be approximately $14.8 million.

Each share of Series 18 Preferred Stock will have a stated value of $1,000 per share and will be convertible at the option of the holder, at any time prior to the automatic conversion of such shares in certain circumstances, into a total of 15 million shares of registered common stock at a conversion price of $1.00 per share of common stock.  Shares of the Series 18 Preferred Stock will receive dividends in the same amount as any dividends declared and paid on shares of common stock, but would be entitled to a liquidation preference over the common stock in certain liquidation events.  The Series 18 Preferred Stock will have no voting rights on general corporate matters.

CTI plans to use the net proceeds from the Offering to continue Phase 3 trials of pacritinib and to support the commercialization of PIXUVRI® (pixantrone) in Europe as well as for general corporate purposes, which may include, among other things, funding research and development, preclinical and clinical trials, the preparation and filing of new drug applications and general working capital.  The Offering is expected to close on or about September 18, 2013.

The securities described above are being offered by CTI pursuant to a shelf registration statement previously filed with the Securities and Exchange Commission (the "SEC"), which the SEC declared effective on Novemb
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BGI Tech and South Texas Accelerated Research Therapeutics Initiate Collaboration to Advance Unique San Antonio 1000 Cancer Genome Project
2. Breckenridge Completes Acquisition of Certain Cypress Products from Pernix Therapeutics
3. Sorrento Therapeutics Secures Rights to Biomiga Diagnostics Therapeutic Drug Monitoring Device for Development of Personalized Paclitaxel Cancer Therapy
4. Sorrento Therapeutics Completes IgDraSol Merger
5. MicroConstants China In-licenses Phase 2 Liver Cancer Drug from Canadian Pertinax Therapeutics
6. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference
7. Sorrento Therapeutics to Present at Two Healthcare Conferences
8. Mast Therapeutics Hosting 2nd Annual Sickle Cell Disease Therapeutics Conference On September 19, 2013
9. Signature Therapeutics, Inc., Presents Four Scientific Posters Today at PAINWeek 2013 Meeting
10. ResearchMoz.us: Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
11. NaZura BioHealth Spun-out from Elcelyx Therapeutics to Advance Lovidia for Weight Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015  Northwest Biotherapeutics, Inc. (NASDAQ: NWBO )("NW Bio"), ... operable and inoperable solid tumor cancers, announced today that CEO ... Annual Phacilitate Immunotherapy Forum in Washington D.C. ... take place on January 26 at 10:30 a.m. EST at ...
(Date:1/23/2015)... , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( ... of directors of Advaxis, Inc. ("Advaxis" or the "Company") ... has breached its fiduciary duties to shareholders. ... an investing website reporting that Advaxis had misrepresented the ...
(Date:1/23/2015)... 23, 2015  iMD Companies, Inc. (ICBU) has repositioned itself as ... and grab a foothold in the hydroponic, hemp and medical ... a presence in the sector, and recently partnering with the ... hemp and medical marijuana, iMD is committing to bring its ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... Global Real Estate Consultants has helped Boehringer Ingelheim ... in Fremont. Global Real Estate Consultants ... transparency in the Fremont commercial real estate market specifically ... ft. state-of-the-art manufacturing facility with pilot plant and process ...
... Scientific Corporation (NYSE: BSX ) today ... (FDA) has approved its Renegade® HI-FLO™ Fathom® Pre-Loaded ... embolic and therapeutic materials into the peripheral vasculature. ... radiologists for minimally invasive procedures to treat uterine ...
Cached Medicine Technology:Boehringer Ingelheim to Purchase Amgen's Fremont (USA) Facility 2Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System 2Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System 3Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System 4
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in Glendale, AZ has ... (PPHA). The PPHA's passion for others' well-being and shared ... treated for obstructive sleep apnea (OSA) has propelled them into ... the valley. The most recent plans for an event will ...
(Date:1/22/2015)... is a famous wedding dress company offering many trendy designs. ... Facebook, Twitter, and Pinterest. The fans will have an opportunity ... every week. , Moreover, the company has extended its 2015 ... homepage for more information. , Angelweddingdress is a ...
(Date:1/22/2015)... January 22, 2015 The federal court overseeing ... U.S. District Court, Southern District of West Virginia has upheld ... that proceeding’s first bellwether trial. In an Order dated January ... trial after finding that C.R. Bard had not proven a ...
(Date:1/22/2015)... 22, 2015 Thousand of GranuFlo lawsuits ... recalled its GranuFlo and NaturaLyte dialysis concentrates continue to ... U.S. District Court, District of Massachusetts, Bernstein Liebhard LLP ... Court has remanded a case filed by the state ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post ... insurance . , Purchasing an accidental death and dismemberment ... This type of rider provides benefits if the insured dies ... a lesser form of life insurance. , AD&D is ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
... study has suggested that patients who are at a high ... combination of vitamins E and C// plus ibuprofen. This therapy ... a mutated gene for apolipoprotein, APOE-4, which is a high-risk ... ,Researchers at the Johns Hopkins University in Baltimore monitored nearly ...
... Anbumani Ramadoss made a reassuring announcement that will bring hope ... 48 additional centers to be instituted, the government will realize ... people in the next two months. This will indeed provide ... of AIDS/HIV. ,In the words of Anbumani Ramadoss ...
... at the University of Edinburgh, it is understood that ... effect on the liver cells. These nanoparticles are ... goods such as paint, sunblock, food, cosmetics and clothes. ... smaller than the width of a human hair, with ...
... likely to experience depression, according to a new study. Lee ... monitored about 460 Boston women aged 36 and 45 and ... prone to depression. ,The study appears in the ... study found that these pre-menopausal women were prone to suffer ...
... The African Union and World Health Organization must do something ... medicinal plants// can be preserved in African countries. ... Brazzaville, Congo, last week. It is widely known that almost ... men for their health needs and researchers are increasingly looking ...
... previous study that high dose of chromium is used ... in specific populations// of patients with type 2 diabetes. ... by Dr. Nanne Kleefstra, of Isala Clinics, Zwolle, the ... does not improve blood-sugar control or other parameters in ...
Cached Medicine News:
... Stainless steel. Lamp supplied with blade. ... high quality standard incandescent laryngoscope blades. ... been continually refined through many years ... minimize maintenance requirements. They are manufactured ...
... blades are designed with the clinician in ... can be removed to simplify cleaning - ... Our unique snap-on mechanism eliminates screws that ... are interchangeable with other green coded fiber ...
... blades are designed with the clinician in ... can be removed to simplify cleaning - ... Our unique snap-on mechanism eliminates screws that ... are interchangeable with other green coded fiber ...
Rigid plastic. Single use. Non-Sterile. The disposable laryngoscope blade that fits on a standard handle. Made of extremely rigid plastic. Bright white light out-performs metal blades. Single patient...
Medicine Products: